Narrative review / 2009
A review outlines progress in migraine science, noting obesity, inflammation, allodynia, and medications as potential factors in migraine progression.
This narrative review summarizes advances in migraine science across clinical practice, epidemiology, and pathophysiology during the triptan era. Research demonstrated that migraine is a brain disorder originating in trigeminal neuronal pathways rather than blood vessels. Furthermore, longitudinal epidemiologic studies identified factors that determine migraine prognosis, raising questions about progression determinants such as obesity, inflammation, allodynia, and medications.
- Study type
- Narrative review
- Who was studied
- Individuals with migraine
- What was measured
- Migraine diagnosis, pathophysiology, prognosis, and progression mechanisms
THE PAPER
Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.
Bigal ME, Ferrari M, Silberstein SD, Lipton RB, Goadsby PJ. Headache, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.